Veracyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.About VCYT
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia.
CEOMarc A. Stapley
CEOMarc A. Stapley
Employees824
Employees824
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2006
Founded2006
Employees824
Employees824
VCYT Key Statistics
Market cap3.38B
Market cap3.38B
Price-Earnings ratio112.64
Price-Earnings ratio112.64
Dividend yield—
Dividend yield—
Average volume701.51K
Average volume701.51K
High today$43.00
High today$43.00
Low today$42.11
Low today$42.11
Open price$42.62
Open price$42.62
Volume222.38K
Volume222.38K
52 Week high$50.71
52 Week high$50.71
52 Week low$22.61
52 Week low$22.61
Stock Snapshot
As of today, Veracyte(VCYT) shares are valued at $42.77. The company's market cap stands at 3.38B, with a P/E ratio of 112.64.
As of 2025-12-25, Veracyte(VCYT) stock has fluctuated between $42.11 and $43.00. The current price stands at $42.77, placing the stock +1.6% above today's low and -0.5% off the high.
Veracyte(VCYT) shares are trading with a volume of 222.38K, against a daily average of 701.51K.
During the past year, Veracyte(VCYT) stock moved between $22.61 at its lowest and $50.71 at its peak.
During the past year, Veracyte(VCYT) stock moved between $22.61 at its lowest and $50.71 at its peak.
Analyst ratings
77%
of 13 ratingsBuy
76.9%
Hold
15.4%
Sell
7.7%
People also own
Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.